Kaletra (lopinavir/ritonavir) oral solution, 2 bottle pack containing 2-ml oral dosing syringes: Presence of amide particles in 2-ml oral dosing syringes

Table of contents

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Key facts

Medicine name
Kaletra
Active substance
  • lopinavir
  • ritonavir
Therapeutic area (MeSH)
HIV Infections
Procedure number
EMEA/H/C/000368
DHPC type
Quality defect
Dissemination date
23/12/2020

How useful was this page?

Add your rating